CMHC Faculty Spotlight

Get to know our faculty members, and gain further information surrounding their backgrounds and expertise, through multimedia videos.

Faculty Spotlight

Tips and Pearls for Management of Cardio-renal Risks in Patients

Watch as CMHC Faculty Pam Taub MD and Ajay Singh MD recapped cardio-renal session at CMHC Annual 2023, where they discussed how cardiologists and nephrologists can work together to tackle cardio-renal diseases, including the latest cardio-renal therapies. (Recorded October 21, 2023)

Watch Now

Looking Beyond LDL-C to Address ASCVD Risk

Looking Beyond LDL-C to Address ASCVD Risk Watch as CMHC Faculty Christie Ballantyne, MD, Robert Eckel, MD, Erin Michos, MD, Patrick Moriarty, MD, and Paul Ridker, MD, discuss practical pearls about the spectrum of residual ASCVD risk, including:

Inflammation
Statin intolerance
Elevated triglycerides
Lp(a)

Recorded October 20, 2023

Watch Now

Comprehensive Management of Type 2 Diabetes: Tips and Pearls

Watch as CMHC faculty Juan Frías, MD and Shivani Agarwal, MD discuss important pearls in the management of type 2 diabetes, including screening for social determinants of health (SDOH), the impact of SDOH on treatment, culturally-sensitive care, as well as the importance of early glycemic control, screening, and GDMT optimization (recorded October 20, 2023).

Watch Now

Expert Perspectives: Recap of Important Updates in Cardiometabolic Medicine 2023

Watch as CMHC faculty Christie Ballantyne, MD, Robert Eckel, MD, Keith Ferdinand, MD, and Anne Peters, MD recap some of the main developments in 2023 across the cardio-renal-metabolic health as discussed at the 18th CMHC Annual meeting, including in obesity, diabetes, dyslipidemia/ASCVD risk, hypertension, and more (recorded October 19, 2023).

Watch Now

Which is Better, Pharmacotherapy or Bariatric Surgery to Manage Obesity?

Watch Drs. Ryan and Still discuss the pros and cons of both pharmacotherapy and bariatric surgery while managing people with obesity. (Recorded October 19, 2023)

Watch Now

Digital Health Technologies for Cardiometabolic Health: Barriers and Perspectives

Watch CMHC Faculty Francoise Marvel, MD and Daichi Shimbo, MD discuss challenges and practical pearls for the use of digital health technologies, focusing on remote blood pressure monitoring and telehealth visits (recorded October 18, 2023).

Watch Now

Significance of Digital Health in Reducing Cardiometabolic Risks

Watch Dr. Seth Martin, MD, MHS, discussing the significance of the role of technology and digital health in cardiometabolic risk reduction. (Recorded October 18, 2023)

Watch Now

Expert Perspectives on Available Digital Intervention for Diabetes Care

Watch Drs. Tsimikas, Aleppo, and Shah discuss the benefits of digital interventions, including CGMs while managing people with diabetes. (Recorded October 18, 2023)

Watch Now

Unique Cardiometabolic Risk Factors in Women

Rachel Bond, MD, System Director of the Women's Heart Health Program at Dignity Health in AZ, has a conversation with Chrisandra Shufelt, MD, Professor of Medicine at Mayo Clinic in FL, about unique cardiometabolic risk factors in women. They discuss the impact of adverse pregnancy outcomes across the lifespan and changes associated with the menopause transition on overall cardiometabolic risk assessment, as well as important clinical pearls in this setting. (Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.)

Watch Now

Disparities in the Management of Type 2 Diabetes in Women

Vanita Aroda, MD, Associate Professor of Medicine at Harvard Medical School, and Katherine Tuttle, MD, Professor of Medicine at the University of Washington, discuss current disparities in the treatment of women with type 2 diabetes and cardiorenal risk despite the evidence and breadth of available agents. They discuss that women are less likely to receive guideline-directed medical therapy, including both older and newer agents, and less likely to enroll in clinical trials, as well as the need to recognize and address these disparities. (Recorded during 2023 CMHC's Women's Health Masterclass, August 19, 2023.)

Watch Now

Obesity & Lifestyle in Women

2023 CMHC's Women's Health Masterclass Co-Chairs Erin Michos, MD and Pam Taub, MD recap the obesity & lifestyle sessions, and in conversation with Fatima Rodriguez, MD, discuss practical pearls for the management of obesity in women across the lifespan, including the synergy between lifestyle interventions and pharmacotherapy, and how to facilitate the dialogue in patients with overweight and obesity to improve overall cardiovascular risk. (Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.)

Watch Now

Screening for Chronic Kidney Disease

Rajiv Agarwal, MD, Professor of Medicine at Indiana University School of Medicine, discusses practical pearls about the screening and diagnosis of chronic kidney disease (CKD), including the importance of albuminuria for the proper screening and risk stratification.(Recorded May 20, 2023.)

Watch Now

The Link Between Chronic Inflammatory Conditions and Cardiovascular Risk

Brittany Weber, MD, PhD, Director of the Cardio-Rheumatology Clinical at Brigham and Women's Hospital, discusses the role of systemic inflammation in promoting cardiovascular risk, the link between systemic inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, and others) and cardiovascular adverse events, and how cardiologists and rheumatologists can work together to manage patients with these comorbid conditions.(Recorded May 19, 2023.)

Watch Now

Cardiorenal Risk Reduction in T2DM

During this interview, Jennifer Green, MD, Professor of Medicine at Duke, discusses the multimorbidity in patients with type 2 diabetes, the role of inflammation as a driver of multimorbidity in this setting, as well as practical pearls for the utilization of newer cardio-renal protective agents in these patients. (Recorded on May 20, 2023.)

Watch Now

The Value of Attending CMHC

Brittany Weber, MD, PhD, Director of the Cardio-Rheumatology Clinical At Brigham and Women's Hospital in Boston talks about her impressions of 2023 CMHC Spring and the need for multidisciplinary clinician education to better address the needs of patients with systemic inflammatory conditions and increased cardiovascular risk. (Recorded May 19, 2023.)

Watch Now

Inflammation and Current Concepts in the Treatment of Hypertension

CMHC Co-Chair George Bakris, MD, Professor of Medicine at University of Chicago, reviews the association between inflammation and hypertension, as well as provides important clinical pearls for the management of hypertension and how to best utilize the existing treatment options. (Recorded May 19, 2023.)

Watch Now

A Preview of 2023 CMHC Annual

CMHC Co-chairs Christie Ballantyne, MD and Robert Eckel, MD, and CMHC Senior Planning Committee Member Pamela Morris, MD, preview in detail 2023 CMHC Annual sessions, as well as the benefits of attending the meeting, which will take place October 18-21, 2023 in Boston.CMHC Co-chairs Christie Ballantyne, MD and Robert Eckel, MD, and CMHC Senior Planning Committee Member Pamela Morris, MD, preview in detail 2023 CMHC Annual sessions, as well as the benefits of attending the meeting, which will take place October 18-21, 2023 in Boston. (Recorded May 20, 2023.)

Watch Now

Inflammation in Heart Failure

CMHC Faculty, Ileana Piña, MD, Professor of Medicine Thomas Jefferson University, discusses the connections between inflammation and heart failure, trials looking at targeting inflammation in this setting, and the importance of shared decision-making in treating patients with heart failure. (Recorded on May 19, 2023.)

Watch Now

Obesity, Inflammation, and Cardiovascular Risk

CMHC co-chair Christie Ballantyne, MD and Erin Michos, MD discuss the biology behind inflammation and obesity, obesity as an underappreciated but major CVD risk factor, and the ever-changing landscape of obesity treatment, with several approaches that have been recently approved or are in clinical development. They also share important practical pearls about the role of newer anti-obesity medications in conjunction with lifestyle for the long-term management of obesity. (Recorded at 2023 CMHC Spring, May 19, 2023.)

Watch Now

Lifestyle, Diet, Physical Activity, and Inflammation

CMHC co-chair Robert Eckel, MD moderates a conversation with Chip Lavie, MD, Virend Somers, MD, and Pam Taub, MD about the interesting intersection between inflammation and lifestyle. The panel shares practical pearls about the role of diet, physical activity, stress and disrupted sleep on inflammation and the importance of addressing these comprehensive lifestyle components to improve cardiometabolic health. (Recorded at 2023 CMHC Spring, May 19, 2023.)

Watch Now

Emerging Therapies for Resistant Hypertension

Cardiometabolic Health Congress co-chair George L. Bakris, MD, provides a brief overview of the evolving landscape of emerging treatment options for resistant hypertension, recorded on February 14, 2023.

Watch Now

Interpreting the Data with Tirzepatide

In an interview with CMHC co-chair Dr. Anne Peters, Juan Frías, MD, shared his thoughts about the data with tirzepatide across key phase 3 trials, and the potential role of this agent in the management of patients with type 2 diabetes, as well as in the management of obesity (recorded October 21, 2022).

Watch Now

Continuous Glucose Monitoring in Type 2 Diabetes

In this interview, CHMC co-chair Anne Peters, MD and Irl Hirsch, MD share some important practical pearls about the importance of continuous glucose monitoring (CGM) and how to better utilize this approach in patients with type 2 diabetes (recorded October 21, 2022).

Watch Now

Recap of Important Updates in Cardiometabolic Medicine in 2022

CMHC co-chairs Drs. Robert Eckel, George Bakris, Christie Ballantyne and CMHC Senior Planning Committee members Drs Deepak Bhatt and Keith Ferdinand recap important highlights of key trials and developments in cardiometabolic medicine in 2022, including obesity, hypertension, chronic kidney disease, heart failure, dyslipidemia, atherothrombosis and more. (recorded October 20, 2022).

Watch Now

Dyslipidemia, Type 2 Diabetes, and Polypharmacy in Older Adults

CMHC co-chair, Dr. Robert Eckel interviews Joseph Saseen, PharmD, Marie McDonnell, MD, and Kenneth Feingold, MD, to discuss important perspectives and clinical pearls about the management of dyslipidemia, type 2 diabetes, as well as the impacts of polypharmacy and minimizing drug-drug interactions in older adults (recorded October 19, 2022).

Watch Now

Hypertension & Healthy Lifestyle in Older Adults

Blood pressure control and living a healthy lifestyle are key in the management of cardiometabolic risk, however, they can be challenging to optimize in older adults. In this interview, CMHC co-chair Robert Eckel, MD interviews Drs. Dennis Villareal and Dena Rifkin to share some additional perspectives on how to better manage hypertension and encourage healthy lifestyle modifications in this population (recorded October 19, 2022).

Watch Now

Dyslipidemia Management & ASCVD Risk Reduction

During this interview, Christie Ballantyne, MD; Pam Taub, MD; Pam Micho, MD, and Michael Blaha, MD discusses important topics in ASCVD risk, including imaging modalities in risk stratification, the evolving landscape of lipid-lowering therapies, and residual ASCVD risk beyond LDL-C (recorded October 21, 2022).

Watch Now

Breaking the Glass Ceiling: Increasing the Representation of Women in Clinical Trial Leadership

Moderated by Pam R. Taub, MD, FACC, this panel of experts include Mohamed A. Eid, MD, MPH, MHA; Roxana Mehran, MD; JoAnne Foody, MD; Kelly Lewis, PharmD; and Christie M. Ballantyne, MD. These expert faculty and industry leaders discussed the significance of including more women leaders in cardiovascular clinical trial research. During this engaging panel discussion, they also emphasized developing the skill set, experience, and knowledge that is required to run a successful clinical trial so that more women can take leadership in the current and future trials. (recorded Sept. 2022)

Watch Now

Cultivating Calm Amidst the Chaos

Dr. Ramona Master, a board-certified internal medicine doctor, is dedicated to providing outstanding care built on compassion and personalized attention. During this talk she emphasized on "healing the healers" by developing mental fitness along with career and physical well being. She highlights the need of self compassion and self care which is often left behind while priortization among women physicians. (recorded Sept. 2022)

Watch Now

Perspectives on Diabetes Management

CMHC Chair Anne L. Peters, MD, talks with Leigh Perreault, MD, Lawrence A. Leiter, MD, and Grazia Aleppo, MD, about the recap of their sessions presented at 2022 CMHC Spring. The topics include the management of patients with diabetes across the continuum, including prediabetes, balancing glycemic control with cardiorenal risk management, the evolution of insulin therapy, and emerging treatment options (recorded April 2022).

Watch Now

Diabetes Technology: CGM and Beyond

CMHC Chair Anne L. Peters, MD, moderates a discussion with Steven J. Russell, MD, PhD, and Viral Shah, MD, about practical pearls for the application of diabetes technology, including CGM and beyond, as well as current and future implications for patient care (recorded April 2022).

Watch Now

Management of Obesity Across the Spectrum

CMHC Chair Robert H. Eckel, MD, moderates a lively discussion with Donna H. Ryan, MD and Holly R. Wyatt, MD about the practical pearls for the management of patients with obesity, including how to initiate the conversation with the patient, setting achievable treatment goals, motivational interviewing and addressing the stigma of obesity (recorded April 2022).

Watch Now

Health Disparities in Obesity Management

CHMC Chair Robert H. Eckel, MD, moderates a discussion with Fatima Cody Stanford, MD, and CMHC Senior Planning Committee Member Keith C. Ferdinand, MD, about current disparities in the management of cardiometabolic risk, with a focus on obesity. They also discuss practical approaches to address some of these disparities (recorded April 2022).

Watch Now

NAFLD and NASH: Advances in Screening & Treatment

CMHC Chair Robert H. Eckel, MD, interviews Kenneth Cusi, MD, about the current state of management in NAFLD and NASH, including the impact of cardiometabolic disease on NAFLD/NASH, implications for screening and diagnosis, as well as current and emerging approaches for diagnosis and treatment (recorded April 2022).

Watch Now

Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?

Watch as CMHC Chair Christie M. Ballantyne, MD moderates an engaging interview with Pam R. Taub, MD, and Salim S. Virani, MD, PhD, recapping a debate at 2022 CMHC Spring titled "Drawing the Line Between Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?" (recorded April 2022).

Watch Now

Familial Hypercholesterolemia: Updates and Perspectives

CMHC Chair Christie M. Ballantyne, MD, interviews Robert S. Rosenson, MD, to recap a talk given at 2022 CMHC Spring on familial hypercholesterolemia (FH). During this interview, Dr. Rosenson overviews new and emerging treatment options for FH, and implications for patient care (recorded April 2022).

Watch Now

Cardiometabolic Centers of Excellence: A Novel Care Model

CMHC Chair Robert H. Eckel, MD, has a discussion with Mikhail N. Kosiborod, MD, recapping the keynote address at 2022 CMHC Spring, which focused on the creation of cardiometabolic centers of excellence as a novel and very much needed model to comprehensively treat cardiometabolic patients to improve quality and outcomes. Dr. Kosiborod has been at the forefront of this approach, and his group has founded the Cardiometabolic Center Alliance, which is dedicated to provide training and materials to help establish these centers across the country (recorded April 2022).

Watch Now

Perspectives on Nutritional Approaches for Cardiometabolic Patients

CMHC Chair Robert H. Eckel, MD, moderates a discussion with David S. Ludwig, MD, PhD, and Holly R. Wyatt, MD about the best dietary approaches to target obesity and cardiometabolic risk, including the role of low-carbohydrate diets, other nutritional approaches/diets, and the individualization of these nutritional approaches for cardiometabolic patients (recorded April 2022).

Watch Now

CMHC Annual 2021 Rare Obesity Disorders Panel

CMHC Chair Robert Eckel, MD, recaps the session on rare obesity disorders discussed at the 16th Annual CMHC with session presenters Joan Han, MD, and Clair Francomano, MD. The session discussed monogenic disorders of obesity, including leptin pathway defects and Alström syndrome, as well as practical pearls for screening, diagnosis, and treatment.

Watch Now

CMHC Annual FDA Updates #2

Watch CMHC Chairs Christie Ballantyne, MD and George Bakris, MD, as well as CMHC Senior Planning Committee member Keith C. Ferdinand, recap clinical trial & FDA updates on dyslipidemia and chronic kidney disease discussed at the 16th Annual CMHC

Watch Now

CMHC Annual 2021 Rare CV Disorders Panel

Senior Planning Committee member Keith C. Ferdinand, and faculty members Ola Akinboboye MD, MD, John L. Jefferies, MD, and Sonja Bartolome MD, FCCP recap the rare CV disorders session which discussed the screening, diagnosis, and treatment of Transthyretin Amyloid Cardiomyopathy, Fabry Disease, and Pulmonary Arterial Hypertension.

Watch Now

Ken Fujioka, MD | Alice Lichtenstein, DSc | Andrew Freeman, MD | Kim A. Williams, Sr., MD

CMHC West Chair Ken Fujioka, M.D. leads a spirited panel discussion on the current state of dietary approaches for cardiometabolic health with Alice Lichtenstein, DSc, Andrew Freeman, MD and Kim A. Williams, Sr., MD.

Watch Now

Christie M. Ballantyne, MD | Deepak L. Bhatt, MD, MPH

CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Deepak L. Bhatt, MD, MPH discuss antithrombotics in diabetic patients.

Watch Now

Christie M. Ballantyne, MD | Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Pamela B. Morris, MD discuss the new era of LDL-C lowering.

Watch Now

George L. Bakris, MD | Clyde W. Yancy, MD, MSc, MACP

CMHC Chair, George L. Bakris, MD and Senior Planning Committee member Clyde W. Yancy, MD, MSc, MACP discuss gender equality and race issues in the treatment of heart failure.

Watch Now

Jay S. Skyler, MD, MACP | Irl B. Hirsch, MD

CMHC Chair, Jay S. Skyler and Irl B. Hirsch, MD discuss insulin access and cost

Watch Now

Jay S. Skyler, MD, MACP | Lawrence Blonde, MD

CMHC Chair, Jay S. Skyler and Lawrence Blonde, MD discuss the updates on cardiovascular outcomes trials.

Watch Now

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Ralph La Forge, MSc, FNLA, CLS

CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Ralph La Forge, MSc, FNLA, CLS discuss cardiometabolic risk management in American Indians and Alaska Native Women.

Watch Now

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Deepak L. Bhatt, MD, MPH

CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Deepak L. Bhatt, MD, MPH discuss the role of aspirin therapy for CVD prevention in women.

Watch Now

Robert H. Eckel, MD | Christos S. Mantzoros, MD, DSc

CMHC Chair Robert H. Eckel, M.D., and faculty member Christos S. Mantzoros, MD, discuss how fatty liver diseases such as NASH, NAFLD, etc., are directly related to cardiometabolic diseases.

Watch Now

Lawrence Blonde, MD | Eric D. Peterson, MD

Drs. Lawrence Blonde and Eric Peterson discuss the role of Big Data and Real-World Evidence in Cardiometabolic Health.

Watch Now

Peter A. McCullough, MD, MPH | Andy Y. Lee, MD | Gurusher S. Panjrath, MD, FACC, FAHA

Drs. Peter McCullough, Gurusher Panjrath, and Andy Lee discuss how Iron deficiency is underdiagnosed and is common in heart failure.

Watch Now

George L. Bakris, MD | Biff F. Palmer, MD | Matthew R. Weir, MD

CMHC Chair George Bakris and experts Biff Palmer and Matthew Weir discuss long-term management of hyperkalemic patients with HF and CKD.

Watch Now

Dr. Jessup | Dr. Butler | Dr. Morris | Dr. Piña

Drs. Jessup, Butler, Morris and Piña discuss the challenges in diagnosis and management of heart failure with preserved ejection fraction.

Watch Now

George Bakris | Raymond Townsend | Michael Weber

A two-part series with CMHC Chair George Bakris and faculty, Raymond Townsend and Michael Weber who discuss integrating the latest hypertension guidelines and addressing the gaps in management.

Watch Now

Christie M. Ballantyne, MD | Leslie Cho, MD

Drs. Christie Ballantyne and Leslie Cho discuss how to manage patients with statin intolerance.

Watch Now

Christie M. Ballantyne, MD | Roger S. Blumenthal, MD

Dr. Blumenthal, who was the part of cholesterol guidelines writing group and co-chair of recent ACC/ AHA prevention guidelines, reviews these guidelines with CMHC Chair Dr. Ballantyne.

Watch Now

Robert H. Eckel, MD | Holly Wyatt, MD | Stephen Devries, MD, FACC

CMHC Chair Robert Eckel asks the experts Dr. Devries and Dr. Wyatt to discuss the importance of overall dietary patterns and lifestyle modifications to improve cardiometabolic health.

Watch Now

Christie M. Ballantyne, MD | Amit Khera, MD, MSc

Drs. Ballantyne and Khera discuss the role of genomics for the prevention of cardiometabolic diseases.

Watch Now

George L. Bakris, MD | Javed Butler, MD, MPH, MBA

Drs. Bakris and Butler discuss the intersection of heart failure, kidney disease and diabetes – Focused mainly on recent clinical trials such as the DAPA-HF trial.

Watch Now

George L. Bakris, MD | Javed Butler, MD, MPH, MBA

Drs. Bakris and Butler discuss the intersection of heart failure, kidney disease and diabetes – Focused mainly on recent clinical trials such as the DAPA-HF trial.

Watch Now

CMHC Faculty Spotlight

Faculty Spotlight

Tips and Pearls for Management of Cardio-renal Risks in Patients

Looking Beyond LDL-C to Address ASCVD Risk

Comprehensive Management of Type 2 Diabetes: Tips and Pearls

Expert Perspectives: Recap of Important Updates in Cardiometabolic Medicine 2023

Which is Better, Pharmacotherapy or Bariatric Surgery to Manage Obesity?

Digital Health Technologies for Cardiometabolic Health: Barriers and Perspectives

Significance of Digital Health in Reducing Cardiometabolic Risks

Expert Perspectives on Available Digital Intervention for Diabetes Care

Unique Cardiometabolic Risk Factors in Women

Disparities in the Management of Type 2 Diabetes in Women

Obesity & Lifestyle in Women

Screening for Chronic Kidney Disease

The Link Between Chronic Inflammatory Conditions and Cardiovascular Risk

Cardiorenal Risk Reduction in T2DM

The Value of Attending CMHC

Inflammation and Current Concepts in the Treatment of Hypertension

A Preview of 2023 CMHC Annual

Inflammation in Heart Failure

Obesity, Inflammation, and Cardiovascular Risk

Lifestyle, Diet, Physical Activity, and Inflammation

Emerging Therapies for Resistant Hypertension

Interpreting the Data with Tirzepatide

Continuous Glucose Monitoring in Type 2 Diabetes

Recap of Important Updates in Cardiometabolic Medicine in 2022

Dyslipidemia, Type 2 Diabetes, and Polypharmacy in Older Adults

Hypertension & Healthy Lifestyle in Older Adults

Dyslipidemia Management & ASCVD Risk Reduction

Breaking the Glass Ceiling: Increasing the Representation of Women in Clinical Trial Leadership

Cultivating Calm Amidst the Chaos

Perspectives on Diabetes Management

Diabetes Technology: CGM and Beyond

Management of Obesity Across the Spectrum

Health Disparities in Obesity Management

NAFLD and NASH: Advances in Screening & Treatment

Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?

Familial Hypercholesterolemia: Updates and Perspectives

Cardiometabolic Centers of Excellence: A Novel Care Model

Perspectives on Nutritional Approaches for Cardiometabolic Patients

CMHC Annual 2021 Rare Obesity Disorders Panel

CMHC Annual FDA Updates #2

CMHC Annual 2021 Rare CV Disorders Panel

CMHC Annual 2021 FDA Updates #1

CMHC Annual 2021 Lipid Management Panel

CMHC Annual 2021 Obesity Management Panel

CMHC Annual 2021 Rare Lipid Disorders Panel

CMHC Annual 2021: Rare Diabetes Disorders Panel

CMHC Annual 2021 Keynote: Sandeep Jauhar

George L. Bakris, MD | Clyde W. Yancy, MD, MSc, MACP

13th Annual CMHC Boston

Jason Tregellas, MD

Robert Eckel, MD | Dan Bessesen, MD | Sangeeta Kashyap, MD | Nin T. Nguyen, MD

Robert Eckel, MD and Alan Chait, MD

Ken Fujioka, MD

Jay Skyler, MD | Steven Kahn, MD | Leigh Perrault, MD | Sanjay Kaul, MD

Clyde Yancy, MD, Bykem Bozkurt, MD, Gurusher Panjrath, MD

Mini Panel Disucssion with Academic Experts in Nephrology and Endocrinology

Keith Ferdinand, MD | JoAnn Lindenfeld, MD | Alanna Morris, MD

Matthew Stryker, MD | Kim Cirtcher, MD

Robert Eckel, MD | Keith Ferdinand, MD

Kate Kirley | Janet Williams

Irl Hirsch, MD | Anne Peters, MD

Robert Eckel, MD | Robert Kushner, MD

Jay Skylar, MD | C. Ronald Kahn, MD

Keith Ferdinand, MD | JoAnn Lindenfeld, MD | Alanna Morris, MD

Ken Fujioka, MD | Spero M. Manson, PhD

Christie M. Ballantyne, MD | Salim Virani, MD, PhD, FACC, FAHA

Ken Fujioka, MD | Alice Lichtenstein, DSc | Andrew Freeman, MD | Kim A. Williams, Sr., MD

Christie M. Ballantyne, MD | Deepak L. Bhatt, MD, MPH

Christie M. Ballantyne, MD | Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA

George L. Bakris, MD | Clyde W. Yancy, MD, MSc, MACP

Jay S. Skyler, MD, MACP | Irl B. Hirsch, MD

Jay S. Skyler, MD, MACP | Lawrence Blonde, MD

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Ralph La Forge, MSc, FNLA, CLS

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Deepak L. Bhatt, MD, MPH

Robert H. Eckel, MD | Christos S. Mantzoros, MD, DSc

Lawrence Blonde, MD | Eric D. Peterson, MD

Peter A. McCullough, MD, MPH | Andy Y. Lee, MD | Gurusher S. Panjrath, MD, FACC, FAHA

George L. Bakris, MD | Biff F. Palmer, MD | Matthew R. Weir, MD